Clinical trial
Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas
NCT07924384 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas
- Lead sponsor
- Institut Curie
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- December 31, 2034
- Enrollment
- 150 (estimated)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.
non-rhabdomyosarcoma soft tissue sarcomas (nrsts)
Arms
As registered; 1 arm.
-
NRSTS group
Single arm for all patients. Tumor samples will be taken for histological and molecular profiling, at baseline (FFPE for routine care or tissue sample from surgery. Blood samples will be taken at baseline and every 3- months up to end of study post surgery.
Primary endpoints
Registered primary outcome measures; 2 primary.
-
Histopathological profiling of NRSTS tumors
Histopathological description of NRSTS tumors based on analysis of tumor tissue in paraffin. Results will be reported as the number and percentage of tumors classified into each histological subtype.
-
Molecular profiling of NRSTS tumors
Molecular profiling of NRSTS tumors combining DNA and RNA profiling, DNA methylation analysis, and clustering. Results will be reported as the number and percentage of tumors presenting identified molecular alterations.
Lead sponsor's other trials
Institut Curie, most recent start first.
+129 more trials See the organization page
Similar trials
Same condition (Neoplasms) and phase, most recent start first.
+2,727 more trials See the condition page